Affymax and Takeda Pharmaceutical Company have announced the availability of OMONTYS (peginesatide) injection to treat anemia due to chronic kidney disease (CKD) in adult patients on dialysis. The once-monthly erythropoiesis-stimulating ...
The Centers for Medicare and Medicaid Services (CMS) has granted a unique product reimbursement code (Q-code) for Affymax's Omontys (peginesatide) injection. Omontys is a once-monthly erythropoiesis-stimulating agent (ESA) for anemia ...
Tags: omontys, peginesatide, CKD